LI; Tindy

Patent Applications and Registrations

Patent applications and USPTO patent grants for LI; Tindy.The latest application filed is for "bisaryl lactams as nrf2 activators".

Company Profile

4.6.14

LI; Tindy - King of Prussia PA
Li; Tindy - Collegeville PA
Li; Tindy - West Haven CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bisaryl Lactams As Nrf2 Activators App 20220002272 - BOEHM; Jeffrey Charles ; et al.	2022-01-06
Nrf2 REGULATORS App 20200079759 - KERNS; Jeffrey K. ; et al.	2020-03-12
Biaryl pyrazoles as NRF2 regulators Grant 10,364,256 - Callahan , et al.	2019-07-30
Arylcyclohexyl pyrazoles as NRF2 regulators Grant 10,351,530 - Callahan , et al. July 16, 2	2019-07-16
NRF2 Regulators App 20190002454 - BOEHM; Jeffrey Charles ; et al.	2019-01-03
Biaryl Pyrazoles As Nrf2 Regulators App 20180282349 - CALLAHAN; James ; et al.	2018-10-04
Arylcyclohexyl Pyrazoles As Nrf2 Regulators App 20180282283 - CALLAHAN; James ; et al.	2018-10-04
Nrf2 REGULATORS App 20180179167 - KERNS; Jeffrey K. ; et al.	2018-06-28
Nrf2 REGULATORS App 20180179187 - KERNS; Jeffrey K. ; et al.	2018-06-28
Nrf2 Regulators App 20160318917 - Boehm; Jeffrey Charles ; et al.	2016-11-03
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 8,829,185 - Dixon , et al. September 9, 2	2014-09-09
Substituted 4-amino-pyrrolotriazine Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis App 20120165314 - Dixon; Julie ; et al.	2012-06-28
Indane amides App 20090247590 - Wang; Yamin ; et al.	2009-10-01
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders Grant 7,109,196 - Wang , et al. September 19, 2	2006-09-19
1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders App 20060189609 - Wang; Yamin ; et al.	2006-08-24
Hydroxamic acids useful in the treatment of hyper-proliferative disorders App 20060063760 - Wang; Yamin ; et al.	2006-03-23
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders Grant 6,900,205 - Wang , et al. May 31, 2	2005-05-31
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders App 20040209866 - Wang, Yamin ; et al.	2004-10-21
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders App 20040014751 - Wang, Yamin ; et al.	2004-01-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.